We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
-0.07%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+476.55%
AUM
$323B
AUM Growth
+$11.5B
Cap. Flow
+$13.1B
Cap. Flow %
4.05%
Top 10 Hldgs %
14.39%
Holding
7,731
New
673
Increased
3,224
Reduced
3,031
Closed
497

Sector Composition

Rank Sector Weight
1 Financials 8.41%
2 Healthcare 8.04%
3 Technology 7.66%
4 Energy 6.94%
5 Consumer Discretionary 6.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RVBD
7551
PUT
DELISTED
RIVERBED TECHNOLOGY, INC COM
RVBD
-1,700
Closed -$36K
EVRY
7552
DELISTED
EVERYWARE GLOBAL INC COM STK (DE)
EVRY
-33,510
Closed -$40K
PAL
7553
DELISTED
NORTH AMERICAN PALLADIUM LTD
PAL
-268,148
Closed -$56K
GFIG
7554
DELISTED
GFI GROUP INC
GFIG
-155,039
Closed -$919K
SLXP
7555
CALL
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
-327,400
Closed -$56.6M
SLXP
7556
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
-1,733,556
Closed -$300M
SLXP
7557
PUT
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
-212,900
Closed -$36.8M
RIOM
7558
DELISTED
RIO ALTO MNG LTD NEW COM SHS (CANADA)
RIOM
-657,600
Closed -$1.62M
AVIV
7559
DELISTED
AVIV REIT INC COM STK (MD)
AVIV
-40,502
Closed -$1.48M
JRN
7560
DELISTED
JOURNAL COMMUNICATIONS INC CL-A
JRN
-246,280
Closed -$3.65M
STRZA
7561
CALL
DELISTED
Starz - Series A
STRZA
-4,400
Closed -$151K
AMZG
7562
DELISTED
AMERICAN EAGLE ENERGY CORP NEW COM STK (NV)
AMZG
-37,918
Closed -$7K
HCF
7563
DELISTED
NEXPOINT CREDIT STRATEGIES FUND
HCF
-14,593
Closed -$178K
PGH
7564
CALL
DELISTED
Pengrowth Energy Corporation
PGH
-4,200
Closed -$13K
EMD
7565
DELISTED
Western Asset Emerging Markets
EMD
-10,286
Closed -$114K
MFT
7566
DELISTED
BLACKROCK MUNIYIELD INVESTMENT QUALITY FUND
MFT
-29,657
Closed -$414K
BIND
7567
DELISTED
BIND THERAPEUTICS INC
BIND
-14,170
Closed -$78K
PFSW
7568
DELISTED
PFSweb, Inc.
PFSW
-22,166
Closed -$244K
CYB
7569
DELISTED
WisdomTree Chinese Yuan Strategy Fund
CYB
-13,472
Closed -$343K
NTP
7570
DELISTED
Nam Tai Property Inc.
NTP
-13,922
Closed -$55K
BDSI
7571
CALL
DELISTED
BioDelivery Sciences International, Inc.
BDSI
-397,300
Closed -$4.17M
MTSC
7572
DELISTED
MTS Systems Corp
MTSC
-3,796
Closed -$287K
NTX
7573
DELISTED
Nuveen Texas Quality Municipal Income Fund
NTX
-25,699
Closed -$368K
NAVG
7574
DELISTED
Navigators Group Inc
NAVG
-9,358
Closed -$364K
AST
7575
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
-46,283
Closed -$312K

Similar funds

Goldman Sachs's Q2 2015 Portfolio in Review

As of Q2 2015, Goldman Sachs held 7,731 positions worth $323B, up 3.7% from $311B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Goldman Sachs deployed $13.1B of net new capital in Q2 2015, opening 673 new positions and adding to 3,224 existing holdings. Its largest new stake was TransUnion: 72,355,340 shares worth $1.82B.

By sector, the portfolio is most concentrated in Financials at 8.4% of assets, up from 8% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Gilead Sciences, an estimated $1.06B trimmed.

  • Goldman Sachs's largest Q2 2015 buy was TransUnion: 72,355,340 shares worth $1.82B.
  • Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $4.27B increase.
  • Goldman Sachs's biggest Q2 2015 reduction was Gilead Sciences, cutting an estimated $1.06B.
  • Goldman Sachs fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $386M.
  • Goldman Sachs's ten largest holdings make up 14% of its $323B portfolio in Q2 2015.
  • Goldman Sachs opened 673 new positions and closed 497 in Q2 2015.
  • Goldman Sachs's portfolio value rose 3.7% quarter-over-quarter to $323B.

Based on Goldman Sachs's 13F filing for Q2 2015, filed 14 Aug 2015.